Introduction
============

Cubital tunnel syndrome (CuTS), also known as delayed ulnar neuritis, is the second most common peripheral nerve compression disease in the upper limb following carpal tunnel syndrome ([@b1-mmr-16-01-0687]). It is estimated that 25 per 100,000 individuals are affected by CuTS in Italy each year, and is two times more common in men, compared with women ([@b2-mmr-16-01-0687]). CuTS can occur as a result of ischemia or mechanical compression by repeated elbow flexion, post-traumatic scarring, anomalous musculature or direct compression, although the exact cause may be difficult to identify ([@b3-mmr-16-01-0687]). Early symptoms in patients can include elbow discomfort, numbness of the little finger, and inflexibility when writing or using tools. In more severe forms of CuTS, the strength of the flexor carpi ulnaris, and flexor muscles of the ring and little fingers are weakened; atrophy of the intrinsic muscle of the hand and mild claw finger deformity can also occur ([@b4-mmr-16-01-0687]). Treatment methods include non-surgical therapies, for example rest, splinting, real-time visualized ultrasound-guided injection and surgical decompression, which can include open *in situ* decompression, anterior transposition and endoscopic decompression ([@b5-mmr-16-01-0687]--[@b8-mmr-16-01-0687]).

At present, investigations of CuTS are focused predominantly on surgical methods, and less on the discussion of pathogenesis and pathology. Although ulnar nerve compression is a common cause of CuTS, its pathogenesis and pathology remain to be fully elucidated. The common areas of entrapment of the ulnar nerve include the arcade of Struthers, the medial intermuscular septum, insertion of the medial head of the triceps, the leading edge of the cubital tunnel retinaculum, and the anconeus epitrochlearis muscle, medial epicondyle, Osborne\'s ligament and flexor-pronator group. Hypertrophy of Osborne\'s ligament is an important cause of ulnar nerve compression ([@b9-mmr-16-01-0687]).

Extensive investigations have been performed to characterize the differences between healthy and diseased ligaments, including alterations in gene expression. MicroRNAs (miRNAs), defined as endogenously expressed, short non-coding RNAs (18--25 nucleotides in length), suppress protein translation through binding to target messenger RNAs (mRNAs). They are expressed at specific stages of tissue development or cell differentiation, and have marked effects on the expression of a variety of genes at the post-transcriptional stage ([@b10-mmr-16-01-0687]).

Previous studies have suggested that miRNAs contribute to the pathogenesis of fibrotic diseases. Hypertrophy of the ligamentum flavum (LF) is crucial in lumbar spinal stenosis (LSS) and is caused primarily by fibrosis. miRNA (miR)-155 is positively correlated with different fibrotic diseases. Previous data have shown that the expression levels of miR155 differ between LF and LSS groups, and between LF and lumbar disc herniation (LDH) groups. Therefore, the fibrosis-associated miR-155 may be important in the pathogenesis of hypertrophic LF ([@b11-mmr-16-01-0687]). However, the role of miRNAs in the development of hypertrophy of the ligaments remains to be elucidated.

To improve understanding of the pathogenesis of CuTS, the present collected examined pachyntic Osborne\'s ligaments and control tendinous tissues. Global miRNA expression levels in the pachyntic Osborne\'s ligaments and control tendinous tissues were examined using microarray techiques. The results showed differences in miRNAs expression levels between the Osborne\'s ligament and control tendinous tissues from patients with CuTS. These findings have important implications for revealing the pathogenesis of CuTS.

Materials and methods
=====================

### Patients and tissue samples

The patients included in the present study comprised six patients with CuTS, which was diagnosed according to their symptoms, neurological examination, electrophysiological examination and imaging. The patients all experienced numbness of the little finger and the ring finger, pain in the elbow and forearm, weakness and clumsiness of the hand and motor deficit, including Froment\'s sign. X-ray imaging of the positive and lateral position of the elbow joint, tangential position of the ulnar nerve, conventional assay and ECG were included in the basic examination. Reductions in the velocity of motor nerve conduction in the patient elbow segments were identified by electromyography. Local color Doppler ultrasound was used to exclude elbow tumor lesions.

The Osborne\'s ligament and control tendinous tissue samples were obtained from four men and two women with CuTS (average age, 53.83 years; range, 31--76 years) who underwent surgery for anterior subcutaneous transposition. Detailed characteristics for the patients are shown in [Table I](#tI-mmr-16-01-0687){ref-type="table"}. During surgery, an arched 6--8 cm incision with a tourniquet control was made posterior to the medial epicondyle. The retrocondylar groove, Osborne\'s ligament and ulnar nerve were identified. Proximally, the ulnar nerve was exposed to the medial intermuscular septum, which was divided to avoid possible future compression. Following division and transection of the Osborne\'s ligament from the cubital tunnel retinaculum, the ulnar nerve was released distally to the two heads of the flexor carpi ulnaris. Soft loops were used to isolate the ulnar nerve, and the ulnar nerve was transposed forward to the medial epicondyle. To stabilize the ulnar nerve, the subcutaneous tissue was sutured using a fascial flap. As medical waste, the Osborne\'s ligaments were collected. In addition \~0.3×1 cm tendinous tissue around the two heads of the flexor carpi ulnaris was excised as a control sample. The specimens wesre collected by the same experienced surgeon in the Department of Orthopedics of Tianjin Medical University General Hospital (Tianjin, China). The Tianjin Medical University General Hospital Medical Ethics Committee approved the consent forms and protocol for evaluating the tissues. Written informed consent was provided by each patient prior to surgery. The specimens were frozen in liquid nitrogen and stored at −80°C until the microarray was performed.

### RNA isolation

Three groups of stored samples were assayed using an Affymetrix GeneChip 3000 TG system purchased from Affymetrix, Inc. (Santa Clara, CA, USA). First frozen samples were homogenized in QIAzolLysis Reagent (Qiagen GmbH, Hilden, Germany) using the TissueRuptor. Total RNA was precipitated using chloroform and the aqueous phase was mixed with 1.5 volumes of 100% Ethanol. Then total RNA, including miRNAs, was extracted using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) according to the manufacturer\'s protocol. The concentration of RNA was measured using a NanoDrop ND-2000 spectrophotometer (NanoDrop; Thermo Fisher Scientific, Inc., Wilmington, DE, USA), and the purity of RNA was confirmed using spectrophotometry. The optical density 260/280 nm ratio was between 1.90 and 2.10 for each RNA sample.

### Microarray hybridization and data analysis

The RNA quality was assessed using denaturing gel electrophoresis. The Affymetrix GeneChip system was used for hybridization, staining and imaging of the arrays, according to the standard Affymetrix protocol. Following hybridization, the arrays were washed using a Fluidics Station 450 (Affymetrix; Thermo Fisher Scientific Inc.) and then scanned using a Scanner 3000 7G 4C (Affymetrix; Thermo Fisher Scientific Inc.). Quality control analysis was performed using the Affymetrix miRNA QCTool (Affymetrix; Thermo Fisher Scientific Inc.). For each miRNA, multiple probes were spotted on the array, and the mean intensity of these probes was calculated to represent the expression value of the miRNAs. In addition, multiple spots were included as negative controls. For each sample, 1 µl total RNA was hybridized with the miRNA array and further processed in accordance with the manufacturer\'s protocol. Only those miRNAs with significant (P\<0.05) differential expression of ≥2.0-fold change were reported. Array scanning and data analysis were performed using Expression Console™ software version 1.4 (Affymetrix; Thermo Fisher Scientific Inc.), which provides signal estimation and quality control functionality for the Affymetrix GeneChip and Transcriptome Analysis Console software version 1.0 (Affymetrix; Thermo Fisher Scientific Inc.), which performs statistical analysis and provides a list of differentially expressed miRNAs. miRWalk2.0 (<http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/>) ([@b12-mmr-16-01-0687]) was used synthesizing four existing miRNA-target prediction programs (miRanda, miRDB, TargetScan and RNA22), as the commonly used web tools for bioinformatics algorithms, to identify the potential targets of those miRNAs by combined analysis of the mRNAs in the whole genome expression microarray. The Bioconductor gene annotation tool version 3.4 (<http://www.bioconductor.org>) was used to perform Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. A Venn diagram was produced to show the potential common significant GO terms among the five miRNAs (hsa-miR-146b-5p, hsa-miR-21-3p, hsa-miR-185-3p, hsa-miR-615-5p and hsa-miR-663a), which included the majority of the predicted target genes.

### Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis

In total, three miRNAs were identified with significant differences, one differentially upregulated (hsa-miR-1343-3p) and two differentially downregulated (hsa-miR-21-3p and hsa-miR-146b-5p). These three miRNAs were verified using RT-qPCR analysis with the Bio-Rad CFX96 Real-Time PCR system (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Total RNA was isolated from the samples of the other three patients with CuTS using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc.), and this was polyadenylated and reverse-transcribed with a poly (T) adapter into cDNA by miScript Reverse Transcription kit (Qiagen GmbH) according to the manufacturer\'s protocol. Then qPCR was performed using SYBR green dye in a thermal cycler with the following parameters: 1 µl buffer, 4 µl total RNA, 2 µl cDNA, 1 µl specific primers, 4 µl RNase-free water and 10 µl SYBR qPCR Mix. An initial denaturation step at 95°C for 30 min; 40 cycles at 95°C for 5 sec and 60°C for 30 sec. The complete experimental procedure was performed for each sample in triplicate. All primers were synthesized by Shanghai Shenggong Biology Engineering Technology Service, Ltd. (Shanghai, China) and the miRNA-specific primers are listed in [Table II](#tII-mmr-16-01-0687){ref-type="table"}. All data were analyzed using the 2-ΔΔCq method ([@b13-mmr-16-01-0687]) to calculate the differences between the quantification cycle values of the target genes in each sample. P\<0.05 was considered to indicate a statistically significant difference.

### Statistical analysis

All data were analyzed using SPSS statistical software (version 11.5 for Windows; SPSS, Inc., Chicago, IL, USA). Statistical analysis was performed using two-tailed Student\'s *t*-test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Expression profile of miRNAs in the ligament

To investigate the miRNA expression profiles in the pachyntic Osborne\'s ligament, microarray analysis was performed using total RNA from pachyntic Osborne\'s ligaments and control tendinous tissues obtained from patients with CuTS. The expression levels of 60 miRNAs showed significant differential expression between the pachyntic Osborne\'s ligament group and the control group ([Fig. 1](#f1-mmr-16-01-0687){ref-type="fig"}). Among these, only three miRNAs were upregulated, whereas the remaining 67 were downregulated ([Table III](#tIII-mmr-16-01-0687){ref-type="table"}).

### Prediction of miRNA target genes and functional analysis

To elucidate the functionality of the regulated miRNAs, miRNA gene target prediction was performed for the 60 differentially expressed miRNAs using the online freely available software, miRWalk2.0. A total of 1,804 predicted target genes of the three upregulated miRNAs and 67 downregulated miRNAs were found, respectively. Functional annotation of the major target genes were from seven miRNAs (hsa-miR-146b-5p, hsa-miR-21-3p, hsa-miR-185-3p, hsa-miR-615-5p, hsa-miR-659-3p, hsa-miR-663a and hsa-miR-760), which were analyzed by GO enrichment analysis to further evaluate the biological implications of the differentially expressed miRNAs. The possible regulatory pathways of the major target genes were analyzed based on KEGG pathway terms. The GO categories included protein metabolic process, regulation of cell growth, cell cycle process, regulation of cell division, cellular metabolic process and signal transmission. The Venn diagram, which was constructed using the Bioconductor tool, showed that there were certain common significant GO terms among the different miRNAs ([Fig. 2](#f2-mmr-16-01-0687){ref-type="fig"}). According to the analysis of enriched KEGG pathways for the targets identified from the differentially expressed miRNAs, the predicted target genes of the differentially expressed miRNAs were associated with adherent junction, focal adhesion, axon guidance, lysine degradation, other glycan degradation, cell adhesion molecules (CAMs), mitogen-activated protein kinase (MAPK) signaling pathway, retrograde endocannabinoid signaling, ErbB signaling pathway, glycosaminoglycan biosynthesis-heparin sulfate/heparin and neurotrophic signaling pathway ([Table IV](#tIV-mmr-16-01-0687){ref-type="table"}). KEGG pathway analysis revealed a number of underlying biological processes, which may be involved in pachynsis of Osborne\'s ligament and may provide useful clues for further investigating the miRNA targets.

### Validation of miRNA expression by RT-qPCR analysis

In addition to validating the microarray results, RT-qPCR was used to quantify particular miRNAs in the pachyntic Osborne\'s ligament, including the one differentially upregulated miRNA (hsa-miR-1343-3p) and two differentially downregulated miRNAs (hsa-miR-21-3p and hsa-miR-146b-5p), which were closely associated with fibrotic disease following the online database search. As shown in [Fig. 3](#f3-mmr-16-01-0687){ref-type="fig"}, the expression patterns of hsa-miR-1343-3p, hsa-miR-21-3p and hsa-miR-146-5p detected using RT-qPCR were consistent with the microarray data, with significance (P\<0.05).

Discussion
==========

In the present study, the patients examined were all engaged in heavy physical work. Chronic repetitive strain can cause hypertrophy of Osborne\'s ligament in the cubital tunnel, and lead to compression of the ulnar nerve and degenerative ulnar neuritis, which is the most common etiology of CuTS. Naran and Imbriglia ([@b14-mmr-16-01-0687]) showed that 55% of patients engaged in activities, which placed repetitive strain or compression on the ulnar nerve, and 48% percent of patients worked as heavy manual laborers in the population demographics. Another study indicated that the incidence of ulnar nerve entrapment at the elbow was associated with one biomechanical risk factor, which was repetitively holding a tool in position ([@b15-mmr-16-01-0687]). Although several other factors, including cubitus valgus, anomalous musculature and direct compression, can also lead to CuTS, the present study focused on the molecular pathogenesis of degenerative ulnar neuritis triggered by hypertrophy of Osborne\'s ligament ([@b4-mmr-16-01-0687]).

Emerging evidence has demonstrated that dysregulation of miRNAs may contribute to the etiology and pathophysiology of fibrosis and scarring, For example, miR-155 is a fibrosis-associated miRNA, which increases the expression of collagen I and collagen III in fibroblasts, and may be involved in the pathogenesis of LF hypertrophy ([@b11-mmr-16-01-0687]). The inhibition of miR-145 assists in preventing or reducing hypertrophic scarring of the skin by reducing skin myofibroblast activity, and decreasing the expression of α1 type I collagen and secretion of transforming growth factor-β1 (TGF-β) ([@b16-mmr-16-01-0687]). miRNA-21 regulates systemic sclerosis fibrosis via directly targeting TGF-β signaling ([@b17-mmr-16-01-0687]). miR-200b, which regulates the proliferation and apoptosis of human hypertrophic scar fibroblasts, has previously been reported to be associated with hypertrophic scarring by affecting the synthesis of collagen I and III, the expression of fibronectin, and TGF-β1/α-smooth muscle actin signaling ([@b18-mmr-16-01-0687]). However, few studies have examined the effects of miRNAs in hypertrophy of Osborne\'s ligament.

In the present study, the miRNA expression profiles showed differentially expressed miRNAs in pachyntic Osborne\'s ligaments and control tendinous tissues of patients with CuTS, identifying miRNAs and the downstream signaling pathway involved in the mechanism of hypertrophy of Osborne\'s ligament. In total, three upregulated and 67 downregulated miRNAs were found. The three miRNAs (hsa-miR-1343-3p, hsa-miR-21-3p and hsa-miR-146b-5p) were verified using RT-qPCR analysis, and their expression patterns were in accordance with the microarray data, with significance (P\<0.05). These miRNAs have been reported in other fields of investigation. miR-146b-5p and let-7f were validated as miRNA markers differentiating papillary thyroid cancer from other clinical conditions ([@b19-mmr-16-01-0687]). In solid tumors, miR-146b-5p is frequently downregulated, including in prostate cancer, pancreatic cancer and glioblastoma; in glioblastoma cell lines, miR-146b-5p is overexpressed, leading to the silencing of matrix metalloproteinase (MMP) 16 mRNA, inactivation of MMP2, and inhibition of tumor cell migration and invasion ([@b20-mmr-16-01-0687]). Another finding suggested that miR-146b-5p may be associated with pancreatic cancer cell migration and invasion by MMP16, which is a downstream target of miR-146b-5p ([@b21-mmr-16-01-0687]). Osborne\'s ligament is a well-defined fibrous band, which consists of connective tissue cells within collagen fibrils ([@b22-mmr-16-01-0687]). Hypertrophy of Osborne\'s ligament may be associated with abnormal variations of elastic and collagen fibers. MMPs, a large family of endopeptidases, are involved in tissue remodeling and the degradation of extracellular matrix, regulating various processes, including chronic inflammation, metastasis and embryonic implantation. MMP-3 (MT3-MMP; MMP-16) in addition to being fibroblast-associated, it is also involved in the regulation of MMP-2 and in direct matrix turnover, and is also widely expressed and capable of degrading several extracellular matrix components, including type I and III collagen ([@b23-mmr-16-01-0687]--[@b25-mmr-16-01-0687]). Therefore, it was hypothesized that miR-146b-5p may affect the expression of its target, MMP-16, and thus increase collagen fibers to result in hypertrophy of Osborne\'s ligament. miR-21-3p has been found to act as a fibroblast exosomal-derived miRNA, which can induce cardiomyocyte hypertrophy through silencing of its targets, sorbin and SH3 domain containing 2 or PDZ and LIM domain 5 ([@b26-mmr-16-01-0687]). Furthermore, miR-21-3p has previously been reported to be associated with the diagnosis of fibromyalgia ([@b27-mmr-16-01-0687]). Therefore, fibroblast-derived miR-21-3p may be involved in the hypertrophy of Osborne\'s ligament. The present study is the first, to the best of our knowledge, to identify the association between the three miRNAs (hsa-miR-1343-3p, hsa-miR-21-3p and hsa-miR-146-5p) and hypertrophy of Osborne\'s ligament, which may provide novel clues in investigations of hypertrophy of Osborne\'s ligament.

According to the results of the GO analysis in the present study, the predicted target genes were involved in protein metabolic process, regulation of cell growth, cell cycle process, regulation of cell division, cellular metabolic process and signal transmission, among others. These biological processes are likely to be important for the development of hypertrophy of Osborne\'s ligament. KEGG pathway analysis showed that CAMs, the MAPK signaling pathway, retrograde endocannabinoid signaling, the ErbB signaling pathway, glycosaminoglycan biosynthesis-heparin sulfate/heparin and the neurotrophic signaling pathway were among the most relevant pathways for the predicted target genes. Certain signaling pathways of these may be important in the pachyntic mechanism of Osborne\'s ligament, and these results provide a novel theoretical foundation for identifying potential therapeutic targets for CuTS.

TGF-β is a member of a large family of disulfide-bonded cytokines. The TGF-β superfamily members include TGF-β1-3, activin, nodal, bone morphogenetic protein (BMP)-2, -4 and -7, anti-Müllerian hormone/Müllerian inhibiting substance (AMH/MIS) and growth differentiation factor (GDF) 5. The TGF-β superfamily members signal through a unique pair of transmembrane serine-threonine kinases, known as type I and type II receptors, to mediate intracellular small mothers against decapentaplegic (Smad) signaling. The TGF-β/activin/nodal subfamily binds to ALK4, 5 and 7, and activates Smad2/3; whereas the BMP/GDF/MIS subfamily generally binds to ALK1, 2, 3 or 6, and activates Smad1/5/8. Activated Smad2/3 and Smad1/5/8 form a complex with Smad4 and enter the nucleus, where they regulate target gene expression. TGFβ1 signaling has previously been reported to be associated with tissue fibrosis, wound healing and scarring in humans ([@b28-mmr-16-01-0687]--[@b30-mmr-16-01-0687]). In addition, the overexpression of miR-146b-5p can decrease levels of SMAD4 by disrupting TGF-β signal transduction in thyroid cancer ([@b31-mmr-16-01-0687]). These findings, together with those of the present study, support the hypothesis that TGFβ1/Smad signaling may be key in the pathogenesis of pachyntic Osborne\'s ligament and potential therapeutic targets of CuTS, even though this signaling pathway was not predicted by KEGG analysis.

As it is not possible to obtain normal Osborne\'s ligaments from healthy individuals, normal tendinous tissues around the two heads of the flexor carpi ulnaris were collected in patients with CuTS in the present study. It was not possible to confirm that the normal control tissues were entirely normal tendinous tissues. The majority of patients with degenerative ulnar neuritis have different degrees of elbow joint degeneration; therefore, the soft tissues around the bone structure, particularly the tendon, are likely to be degenerated, and this remains to be clarified. These clinical limitations may have affected the experimental results of the present study. In addition, the prediction of miRNA targets by biological analysis alone is insufficient and further experiments are required to verify predicted miRNA targets, for example through the use of miRNA transfection/knockdown and luciferase assays. Therefore, future investigations aim to perform these experiments to confirm the predicted miRNA targets in present study. The identification of the function of the differentially expressed miRNAs and their corresponding predicted target genes is likely to contribute to current understanding of hypertrophy of Osborne\'s ligament.

In conclusion, the miRNA expression profiles of the pachyntic Osborne\'s ligaments in patients with CuTS were significantly different, compared with those of control tendinous tissues. Altered miRNAs may lead to the excessive activation or inactivation of signaling pathways in Osborne\'s ligament. The present study also indicated that differentially expressed miRNAs may be involved in the pathogenesis of CuTS and provided a theoretical foundation for identifying novel clinical treatments for CuTS. The etiology of CuTS is complex and remains to be fully elucidated, however, the present study on the miRNAs of pachyntic Osborne\'s ligaments provided novel information for revealing the pathogenesis and pathology of CuTS.
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![Heat map and unsupervised hierarchical cluster analysis of the differentially expressed miRNAs in pachyntic Osborne\'s ligament groups and control tendinous tissue groups. Columns and rows represent samples and specific miRNAs. The samples were grouped together into the pachyntic Osborne\'s ligament group and control tendinous tissue group, according to their expression pattern. The miRNA clustering tree is shown on the left. The color scale shows the relative expression level of miRNAs as the log (P-value) -transformed values. Red indicates that the miRNA shows markedly different expression in the pachyntic Osborne\'s ligament group, compared with that in the control; yellow indicates less difference in the expression of miRNA between the pachyntic Osborne\'s ligament and control groups. miRNA/miR, microRNA.](MMR-16-01-0687-g00){#f1-mmr-16-01-0687}

![Venn diagram of five miRNAs, including the majority of the predicted target genes. The Venn diagram shows the potential common significant GO terms among five miRNAs (hsa-miR-146b-5p, hsa-miR-21-3p, hsa-miR-185-3p, hsa-miR-615-5p and hsa-miR-663a), which include the majority of the predicted target genes. Different colors represent different miRNAs. The number in the intersection represents the number of common GO terms among the miRNAs. GO, Gene Ontology; miRNA/miR, microRNA.](MMR-16-01-0687-g01){#f2-mmr-16-01-0687}

![Validation of the differential expression of the three miRNAs identified in the microarray using RT-qPCR. RT-qPCR was used to analyze the expression of miR-1343-3p, miR-21-3p and miR-146b-5p in Osborne\'s ligaments from patients with CuTS. Data indicate the relative expression following normalization and values are presented as the mean ± standard error of the mean. \*P\<0.05, vs. control. miRNA/miR, microRNA; CuTS group, pachyntic Osborne\'s ligament tissues from patients with cubital tunnel syndrome; control group, control tendinous tissues from patients with cubital tunnel syndrome; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.](MMR-16-01-0687-g02){#f3-mmr-16-01-0687}

###### 

Characteristics of patients.

  Characteristic             Patient 1    Patient 2    Patient 3    Patient 4   Patient 5   Patient 6
  -------------------------- ------------ ------------ ------------ ----------- ----------- -----------
  Gender                     Male         Female       Male         Male        Female      Male
  Age (years)                61           76           64           53          31          38
  Surgical method            ASCT         ASCT         ASCT         ASCT        ASCT        ASCT
  Side of surgery            Left         Right        Right        Bilateral   Left        Left
  Surgery on dominant side   No           Yes          Yes          Yes         No          No
  Electromyography           Positive     Positive     Positive     Positive    Positive    Positive
  Tinel\'s sign              Positive     Positive     Positive     Positive    Positive    Positive
  Sample application         Microarray   Microarray   Microarray   RT-qPCR     RT-qPCR     RT-qPCR

ASCT, anterior subcutaneous transposition; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.

###### 

Primers used for reverse transcription-quantitative polymerase chain reaction analysis.

  miRNA             miRNA sequence (5′-3′)   Primer sequence (5′-3′)   Primer length (bp)   GC content (%)   Tm (°C)
  ----------------- ------------------------ ------------------------- -------------------- ---------------- ---------
  hsa-miR-21-3p     CAACACCAGUCGAUGGGCUGU    Forward ATT CAA CAC       21                   52               60.2
                                             CAG TCG ATG GGC                                                 
                                             Reverse TAG CTT ATC                                             
                                             AGA CTG ATG TT                                                  
  hsa-miR-146b-5p   UGAGAACUGAAUUCCAUAGGCU   Forward GTG AGA ACT GAA   23                   43               59.9
                                             TTC CAT AGG CT                                                  
                                             Reverse GCA CCA GAA                                             
                                             CTG AGT CCA CA                                                  
  hsa-miR-1343-3p   CUCCUGGGGCCCGCACUCUCGC   Forward TTA TTC TCC       19                   63               60.6
                                             TGG GGC CCG C                                                   
                                             Reverse ATC CCA CCA                                             
                                             CTG CCA CC                                                      

miR/miRNA, microRNA.

###### 

Summary of the significantly differentially expressed miRNAs.

  miRNA               logFC (fold change)   P-value       Sequence (5′-3′)
  ------------------- --------------------- ------------- ---------------------------
  Upregulated                                             
    hsa-miR-7855-5p   1.045103351           0.000425931   UUGGUGAGGACCCCAAGCUCGG
    hsa-miR-422a      1.377981007           0.000219629   ACUGGACUUAGGGUCAGAAGGC
    hsa-miR-1343-3p   0.934668054           0.000311621   CUCCUGGGGCCCGCACUCUCGC
  Downregulated                                           
    hsa-miR-196a-5p   −6.520640993          0.000000057   UAGGUAGUUUCAUGUUGUUGGG
    hsa-miR-1290      −3.225990914          0.000000895   UGGAUUUUUGGAUCAGGGA
    hsa-miR-595       −3.859379525          0.000001060   GAAGUGUGCCGUGGUGUGUCU
    hsa-miR-7110-5p   −3.949821874          0.000006230   UGGGGGUGUGGGGAGAGAGAG
    hsa-miR-3148      −2.477794005          0.000006770   UGGAAAAAACUGGUGUGUGCUU
    hsa-miR-4532      −3.334823954          0.000008990   CCCCGGGGAGCCCGGCG
    hsa-miR-3064-5p   −3.049176967          0.000009880   UCUGGCUGUUGUGGUGUGCAA
    hsa-miR-6792-5p   −1.989451562          0.000010600   GUAAGCAGGGGCUCUGGGUGA
    hsa-miR-7844-5p   −2.838409598          0.000017300   AAAACUAGGACUGUGUGGUGUA
    hsa-miR-4535      −2.017418576          0.000018300   GUGGACCUGGCUGGGAC
    hsa-miR-146b-5p   −5.085472937          0.000020700   UGAGAACUGAAUUCCAUAGGCU
    hsa-miR-3178      −2.277544498          0.000022100   GGGGCGCGGCCGGAUCG
    hsa-miR-297       −4.106551942          0.000028200   AUGUAUGUGUGCAUGUGCAUG
    hsa-miR-21-3p     −3.565524376          0.000037100   CAACACCAGUCGAUGGGCUGU
    hsa-miR-4525      −3.485981804          0.000052800   GGGGGGAUGUGCAUGCUGGUU
    hsa-miR-6789-5p   −1.746637528          0.000054700   GUAGGGGCGUCCCGGGCGCGCGGG
    hsa-miR-6883-5p   −2.808853491          0.000061600   AGGGAGGGUGUGGUAUGGAUGU
    hsa-miR-3149      −1.879048778          0.000066500   UUUGUAUGGAUAUGUGUGUGUAU
    hsa-miR-4502      −2.622259256          0.000070000   GCUGAUGAUGAUGGUGCUGAAG
    hsa-miR-933       −1.918951061          0.000081100   UGUGCGCAGGGAGACCUCUCCC
    hsa-miR-4793-3p   −3.351094169          0.000084600   UCUGCACUGUGAGUUGGCUGGCU
    hsa-miR-6085      −1.483750019          0.000085000   AAGGGGCUGGGGGAGCACA
    hsa-miR-760       −1.736503688          0.000086000   CGGCUCUGGGUCUGUGGGGA
    hsa-miR-6075      −2.645791301          0.000090600   ACGGCCCAGGCGGCAUUGGUG
    hsa-miR-4741      −1.682786276          0.000096200   CGGGCUGUCCGGAGGGGUCGGCU
    hsa-miR-6875-5p   −3.198242537          0.000102689   UGAGGGACCCAGGACAGGAGA
    hsa-miR-6845-5p   −2.537516128          0.000110628   CGGGGCCAGAGCAGAGAGC
    hsa-miR-1180-3p   −3.290772167          0.000120042   UUUCCGGCUCGCGUGGGUGUGU
    hsa-miR-3620-5p   −1.269433220          0.000125189   GUGGGCUGGGCUGGGCUGGGCC
    hsa-miR-663a      −1.826255642          0.000153410   AGGCGGGGCGCCGCGGGACCGC
    hsa-miR-663b      −3.478527017          0.000155267   GGUGGCCCGGCCGUGCCUGAGG
    hsa-miR-3621      −1.444956668          0.000161666   CGCGGGUCGGGGUCUGCAGG
    hsa-miR-4721      −3.187701938          0.000188641   UGAGGGCUCCAGGUGACGGUGG
    hsa-miR-6791-5p   −1.769619706          0.000205615   CCCCUGGGGCUGGGCAGGCGGA
    hsa-miR-1973      −1.699316842          0.000233469   ACCGUGCAAAGGUAGCAUA
    hsa-miR-659-3p    −1.301640751          0.000244329   CUUGGUUCAGGGAGGGUCCCCA
    hsa-miR-4507      −1.921339340          0.000257577   CUGGGUUGGGCUGGGCUGGG
    hsa-miR-6740-5p   −2.050797179          0.000259650   AGUUUGGGAUGGAGAGAGGAGA
    hsa-miR-6816-5p   −1.940639258          0.000282808   UGGGGCGGGGCAGGUCCCUGC
    hsa-miR-6836-5p   −3.707920585          0.000310829   CGCAGGGCCCUGGCGCAGGCAU
    hsa-miR-185-3p    −2.848826390          0.000322188   AGGGGCUGGCUUUCCUCUGGUC
    hsa-miR-4763-3p   −1.844484822          0.000334158   AGGCAGGGGCUGGUGCUGGGCGGG
    hsa-miR-30e-3p    −1.602759453          0.000335463   CUUUCAGUCGGAUGUUUACAGC
    hsa-miR-1237-5p   −1.676336572          0.000348059   CGGGGGCGGGGCCGAAGCGCG
    hsa-miR-6084      −1.326538904          0.000356453   UUCCGCCAGUCGGUGGCCGG
    hsa-miR-4488      −1.219288223          0.000357825   AGGGGGCGGGCUCCGGCG
    hsa-miR-4450      −2.075168762          0.000360412   UGGGGAUUUGGAGAAGUGGUGA
    hsa-miR-3651      −4.214617171          0.000361525   CAUAGCCCGGUCGCUGGUACAUGA
    hsa-miR-4449      −4.741198585          0.000393060   CGUCCCGGGGCUGCGCGAGGCA
    hsa-miR-762       −1.666761846          0.000444374   GGGGCUGGGGCCGGGGCCGAGC
    hsa-miR-6765-5p   −1.765624284          0.000463632   GUGAGGCGGGGCCAGGAGGGUGUGU
    hsa-miR-2277-5p   −0.827734961          0.000465336   AGCGCGGGCUGAGCGCUGCCAGUC
    hsa-miR-3197      −5.698464480          0.000488920   GGAGGCGCAGGCUCGGAAAGGCG
    hsa-miR-615-5p    −3.033691421          0.000502284   GGGGGUCCCCGGUGCUCGGAUC
    hsa-miR-4783-3p   −2.084261251          0.000519843   CCCCGGUGUUGGGGCGCGUCUGC
    hsa-miR-1343-5p   −1.042812782          0.000541584   UGGGGAGCGGCCCCCGGGUGGG
    hsa-miR-6815-5p   −2.100053152          0.000542802   UAGGUGGCGCCGGAGGAGUCAUU

miR, microRNA.

###### 

KEGG pathway analysis for the predicted miRNA targets.

  KEGG pathway                                             P-value    Genes (n)   miRNAs (n)
  -------------------------------------------------------- ---------- ----------- ------------
  Prion diseases                                           0.000000     3         2
  Systemic lupus erythematosus                             0.000000   31          3
  Alcoholism                                               0.000000   39          4
  Adherens junction                                        0.000000   30          9
  Axon guidance                                            0.000000   51          9
  Other glycan degradation                                 0.000003     3         2
  Lysine degradation                                       0.000111   19          9
  Transcriptional misregulation in cancer                  0.000165   65          9
  Cell adhesion molecules                                  0.000215   23          8
  Mitogen-activated protein kinase signaling pathway       0.000567   86          8
  ErbB signaling pathway                                   0.005328   29          8
  Circadian entrainment                                    0.007704   35          6
  Neurotrophin signaling pathway                           0.017656   47          7
  Prostate cancer                                          0.01956    32          5
  Focal adhesion                                           0.025566   67          7
  Long-term potentiation                                   0.032181   25          6
  Retrograde endocannabinoid signaling                     0.032885   33          4
  Glycosaminoglycan biosynthesis-heparan sulfate/heparin   0.041110     8         6

miRNA, microRNA; KEGG, Kyoto Encyclopedia of Genes and Genomes.

[^1]: Contributed equally
